Australian actor Martin Grelis, who appeared in the 1999 first installment of The Matrix film series, has died at the age of 57. “Martin was a bright spark who lit up every room he was in—a talented ...

Fintel reports that on December 15, 2025, BTIG reiterated coverage of Organogenesis Holdings (NasdaqCM:ORGO) with a Buy recommendation. Analyst Price Forecast Suggests 79.50% Upside As of December 6, ...

You can stop looking for glitches in the Matrix—it’s finally been proven that our universe is not merely a simulation running on some powerful alien civilization’s supercomputer. An international team ...

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors ...

ORGO’s AWC declined YoY, which is a significant headwind as it comprises the majority of its sales. However, the decline was mostly due to a delayed Medicare LCD, pressuring demand and product mix.

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for ...

Organogenesis Holdings’ main drivers are its advanced wound-care and surgical biologics that leverage its evidence-rich portfolio. They have a Phase 3 trial on ReNu knee-osteoarthritis, with data ...

Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 43,359 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing ...